The company says the marketing suspension is "temporary" pending a full analysis of the trial, which pointed to higher rates of 30-day mortality among high-risk surgery patients randomized to aprotinin. Medscape Medical News
The FDA has approved the first lotion formulation of adapalene for the topical treatment of acne in patients aged 12 years and older. Medscape Medical News